Results 191 to 200 of about 36,500 (251)
Pitfalls of transcatheter tricuspid valve replacement: lessons from a decade of experience. [PDF]
Fam NP, Kim K.
europepmc +1 more source
Pulmonary artery aneurysm and tuberous sclerosis: case report. [PDF]
Brandão HV, Dias CIC, Moura MVB.
europepmc +1 more source
Molecular Diagnosis and Phenotypic Variability of Noonan Syndrome: Experience from a Romanian Multicenter Study. [PDF]
Nazarie FV +15 more
europepmc +1 more source
Modern approaches to surgical repair of pulmonary valve insufficiency
openaire +1 more source
Isolated tricuspid regurgitation in structurally normal fetal hearts: a systematic review. [PDF]
Bravo-Valenzuela NJ +5 more
europepmc +1 more source
Prenatal Ultrasonographic Detection of Intracardiac Thrombi in Canine Fetuses With Congenital Heart Defects. [PDF]
Valeri F +7 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Idiopathic right pulmonary artery aneurysm with pulmonary valve insufficiency
Catheterization and Cardiovascular Diagnosis, 1996A case of idiopathic right pulmonary artery aneurysm with pulmonary valve insufficiency simulating a mediastinal teratoma occurred in an asymptomatic 13-year-old boy. The key to correct diagnosis was pulmonary angiography. The patient was successfully treated with surgery.
E, Onorato +4 more
exaly +3 more sources
Journal of Thoracic and Cardiovascular Surgery, 2022
According to the current guidelines of pulmonary valve replacement (PVR) for pulmonary insufficiency, the age at the time of PVR is becoming younger. However, recent studies have shown that the improvements in mortality have leveled off, making it important to suppress the cumulative lifetime risk of morbidity.
Yuji Tominaga +2 more
exaly +3 more sources
According to the current guidelines of pulmonary valve replacement (PVR) for pulmonary insufficiency, the age at the time of PVR is becoming younger. However, recent studies have shown that the improvements in mortality have leveled off, making it important to suppress the cumulative lifetime risk of morbidity.
Yuji Tominaga +2 more
exaly +3 more sources

